- Home
- Publications
- Publication Search
- Publication Details
Title
Individualized Therapy for Gastroesophageal Reflux Disease
Authors
Keywords
-
Journal
Molecular Diagnosis & Therapy
Volume 16, Issue 4, Pages 223-234
Publisher
Springer Nature
Online
2012-12-18
DOI
10.1007/bf03262211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism
- (2012) N. G. Hunfeld et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Testing for variants in CYP2C19: population frequencies and testing experience in a clinical laboratory
- (2012) Charles M. Strom et al. GENETICS IN MEDICINE
- Stereoselective pharmacokinetics of stable isotope (+/−)-[13C]-pantoprazole: Implications for a rapid screening phenotype test of CYP2C19 activity
- (2011) David L. Thacker et al. CHIRALITY
- Dose–response relationships of rabeprazole 5, 10, 20, and 40 mg once daily on suppression of gastric acid secretion through the night in healthy Japanese individuals with different CYP2C19 genotypes
- (2011) Seiichi Hayato et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype–phenotype correlation in childhood
- (2011) Ersin Gumus et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prediction of Clopidogrel Low Responders by a Rapid CYP2C19 Activity Test
- (2011) Junichi Tazaki et al. Journal of Atherosclerosis and Thrombosis
- Influence of Different Proton Pump Inhibitors on Activity of Cytochrome P450 Assessed by [13C]-Aminopyrine Breath Test
- (2011) Chise Kodaira et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Distribution of CYP2C19*17 allele and genotypes in an Indian population
- (2011) D. Anichavezhi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs—TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan
- (2011) Takahisa Furuta et al. JOURNAL OF GASTROENTEROLOGY
- Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping
- (2010) S. Miehlke et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease
- (2010) Y. Kinoshita et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes
- (2010) Takahisa Furuta et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect
- (2010) G. L. Kearns et al. DRUG METABOLISM AND DISPOSITION
- Influence of CYP2C19 on the relationship between pharmacokinetics and intragastric pH of omeprazole administered by successive intravenous infusions in Chinese healthy volunteers
- (2010) Yongqing Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C19 genotypes on the pharmacokinetic/pharmacodynamic relationship of rabeprazole after a single oral dose in healthy Chinese volunteers
- (2010) Yu-Cheng Sheng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
- (2010) D. SIBBING et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- [13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole
- (2009) T. FURUTA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
- (2009) Alain Li-Wan-Po et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers
- (2009) Masafumi Nishino et al. DIGESTIVE DISEASES AND SCIENCES
- Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects
- (2009) Chise Kodaira et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19 genotype is associated with symptomatic recurrence of GERD during maintenance therapy with low-dose lansoprazole
- (2009) Takahisa Furuta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) Deepak L. Bhatt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population
- (2008) Katsuyoshi Sugimoto et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers
- (2008) R. Michael Baldwin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) et al. CIRCULATION
- Optimal dose regimens of esomeprazole for gastric acid suppression with minimal influence of the CYP2C19 polymorphism
- (2008) Horng-Yuan Lou et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH
- (2008) Julia Kirchheiner et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects
- (2008) Staffan Ohlsson Rosenborg et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis
- (2008) Fujun Zhao et al. HELICOBACTER
- Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease
- (2008) Naomi Uemura et al. JOURNAL OF GASTROENTEROLOGY
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
- (2008) K. UMEMURA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Plasma concentration of rabeprazole after 8-week administration in gastroesophageal reflux disease patients and intragastric pH elevation
- (2007) Hiro-o Yamano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now